Press "Enter" to skip to content

Posts published in “News”

Aurigene’s Breakthrough CAR-T Therapy: Dr. Reddy’s Laboratories Unveils Promising Phase 1 Results in Fight Against Multiple Myeloma

Aurigene Oncology Limited, a subsidiary of Dr. Reddy’s Laboratories (BSE: DRREDDY) (NASDAQ: RDY), has unveiled promising results from its Phase 1 trial of Ribrecabtagene autoleucel (DRL-1801) — India’s first novel…